<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-KSB
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 1996
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file No. 0-14119-NY
POLYMER RESEARCH CORP. OF AMERICA
(Name of small business issued in its charter)
NEW YORK 11-2023495
- ------------------------------- ----------------------------
(State or other jurisdiction of (IRS Employer Identification
incorporation or organization) Number)
2186 Mill Avenue, Brooklyn, NY 11234
- --------------------------------------- -------
(Address of principal executive offices) (Zip Code)
Issuers telephone number including area code: (718) 444-4300
--------------
Securities registered pursuant to Section 12(b) of the Act:
- -----------------------------------------------------------
NONE
Securities registered pursuant to Section 12(g) of the Act:
- -----------------------------------------------------------
4,000,000 shares of $.01 par value Common Stock
Check whether the issuers: (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes X No
--- --
Registrant's revenues for its most recent fiscal year - $ 5,078,569
-----------
Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B contained in this form, and no disclosure will be contained, to
the best registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-KSB or any amendment to
this Form 10-KSB. Yes X No
--- ---
The aggregate market value of voting stock held by non-affiliates of the
Registrant at February 18, 1997 was approximately $3,588,525 based on the last
sale price of such stock.
As of February 18, 1997, the Registrant had 1,397,820 shares of Common Stock
outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
NONE
1
<PAGE>
ITEM 1 - BUSINESS
Polymer Research Corp. of America ("The Company") was incorporated under the
laws of New York State in 1963. It is principally engaged in research and
development in polymer chemistry, on a contract basis, particularly in the
application of chemical "grafting," i.e., techniques for modification of organic
and inorganic substances. The Company also manufactures and sells products
arising from research activities and textile printing inks.
During 1996, research revenues and products sales accounted for 85 percent and
15 percent of the Company's net revenues, respectively.
For a detailed breakdown of segments of the Company's revenues, income, capital
expenditures and identifiable assets, see Note 13 of Notes to the Financial
Statements.
RESEARCH AND DEVELOPMENT CONTRACT WORK
The Company's principal business is that of research and development on a
contract basis for other companies in the field of polymer chemistry, i.e., the
chemical creation and use of polymers. "Polymers" are essentially compounds of
high molecular weight, such as plastics and resins.
Polymers result from chemical reactions of compounds with low molecular weights,
called "monomers," which react to form a polymer. Generally, a polymerization
reaction (i.e., the chemical creation of a polymer) entails the application of
heat to a solution containing the appropriate monomers, in the presence of a
catalyst; the result of the reaction can include one or more kinds of polymers.
The Company owns several patented processes for chemical "grafting" technology.
Chemical "grafting" refers to processes by which surfaces are bonded together,
or a coating is affixed to a surface, or in depth, through various
polymerization reactions.
Chemical "grafting" is done by treating a surface with one or more solutions
containing monomers, polymers and/or other chemicals. By using heat, catalysts
and/or other appropriate techniques, small "whiskers" grow on the surface being
treated. These "whiskers" are generally polymers which include in their chemical
makeup molecules that remain part of the surface being treated. The "whiskers"
can themselves form a protective coating on a surface or join the "whiskers"
from another surface thus bonding the two surfaces together. Alternately, by
suitable methods, grafting can take place in depth throughout the body of the
substrate, i.e. the product to be grafted.
2
<PAGE>
By using chemical "grafting" techniques, the Company can form a permanent
scratch and corrosion-resistant protective coating on plastics, rubber, metals,
and other substances. Based upon the Company's research, management believes
that there are many other practical applications of these techniques that have
not yet been fully developed or discovered.
Research and development contract work for specific application of its chemical
"grafting" techniques has been done for pharmaceutical companies and
manufacturers of industrial equipment, tires, packaging material, pipes, tubes
and plastic films, and other enterprises. The Company continues to seek and
obtain such research and development contract work.
A majority of the Company's research and development work in chemical "grafting"
is done for customers in the private sector. The Company markets its research
and development services by contacting businesses which might have a use for
chemical "grafting." Typically the Company and the prospective customer
determine the possible application of chemical "grafting" in which the customer
has an interest. The Company then submits a research proposal based on
specifications provided by the prospective customer. If the proposal is
accepted, or if an acceptable proposal is negotiated, the Company enters into a
contract with the customer and commences the research that is required.
A majority of the Company's research and development contracts are for specified
periods of time. Most such contracts extend for a period of three to four months
and are renewable. The remainder of the Company's research and development
contract work is done either on a lump sum or month-to-month basis. The
"typical" monthly payment to the Company under a research and development
contract ranges from $20,000 to $40,000.
Research revenue earned from foreign customers outside the United States
aggregated $1,535,654 for 1996, representing approximately 35% of total annual
research revenues.
Almost all of the research and development contracts provide that if the Company
successfully develops a patentable new process while working on the contract,
the Company will assign patent rights to the customer who then will have the
right to use that process. This right generally extends only for uses which the
Company was hired to do the research, and in some instances, is dependent upon
the customer making specified payments to the Company. The Company believes that
these provisions in its contracts are necessary and have not unreasonably
inhibited the Company's research and development projects for other customers.
3
<PAGE>
The Company employs 5 in-house sales persons plus 3 persons in training to
market its research and development contracts, primarily through bulk mailings
to targeted potential customers.
To date, all of the Company's research and development services have been
related to contracts for customers.
PRODUCTION
The Company manufactures products resulting from research work as an
accommodation for the companies for whom the research work was done.
The Company also has, since its inception, produced and sold color inks, and
components thereof. These products are used by textile businesses for the
printing of textiles.
The manufacture of textile inks is essentially a process of mechanically mixing
solvents, resins, emulsions, gums, oils and pigments to produce a colored ink
which can be printed onto cloth. The Company owns and operates the mixing
machinery for this manufacturing process and acquires the required ingredients
from a variety of sources. The Company is not dependent upon a particular
supplier for the ingredients. The Company's textile inks are solvent-free and
non-polluting.
During 1996, 1995 and 1994, no one customer of the Company accounted for more
than 5% of its sales of textile inks. The Company has no long-term contracts
with its customers for textile inks and maintains approximately a one-month
supply of the ingredients for the textile inks in inventory. The Company fills
95% of all textile ink orders within two business days after their receipt.
The Company's sales of textile inks are dependent upon the decision of textile
companies as to whether they will dye or print their fabrics. Such a decision is
primarily based on fashion trends, with one-color fabrics requiring dyeing and
multi-colored fabrics requiring printing. However, these trends have not had a
material adverse effect on the Company's revenues because the Company has
maintained a reliable customer base in the United States. The sales of printing
inks has not been a significant source of revenues or profits for the Company.
The Company employs 1 in-house salesperson to sell its textile inks. The Company
markets its textile inks to the United States and foreign customers. Foreign
customers account for less than 5% of the Company's textile ink sales.
4
<PAGE>
EMPLOYEES AND EMPLOYEE RELATIONS
As of December 31, 1996, the Company had 49 full-time employees. The President
and the 16 other scientists in the Company's Research Department are engaged in
research and development. The Products Department has 4 employees who are
engaged in the production of items arising from research and textile inks. There
are 8 employees in the sales and marketing departments. In addition, there are
16 clerical employees and 4 maintenance employees.
The Company's technical staff sign nondisclosure agreements whereby they agree
to keep the technical information and processes of the Company confidential. In
those agreements, such technical personnel also agree to unconditionally assign
to the Company all techniques and inventions developed by them in furtherance of
or related to Company projects.
None of the Company's employees are members of a labor union. There have been no
strikes or work stoppages and the Company believes its employee relations are
satisfactory.
COMPETITION
The fields in which the Company does business are highly competitive.
In its contract research and development business, the Company competes with the
in-house research and development staffs of its customers and scientists at
educational institutions and foundations who will do private grant research on
processes to produce materials with characteristics of the types desired by the
Company's customers. The Company also faces potential competition from research
and development companies which are substantially larger than the Company, and
various private laboratories, although the Company believes that it is presently
the only Company doing contract research and development work in the field of
chemical "grafting" for other companies. The Company's "grafting" techniques
include the use of innocuous or mild non-alkaline and non-acidic chemicals. In
addition, the Company's method of grafting, by use of chemicals, is less
expensive than other methods such as gamma-ray grafting.
In its textile ink business, the Company faces intense competition from a
variety of competitors, many of whom are substantially larger and have
significantly greater resources, reputations and marketing abilities than does
the Company, and the Company is not a significant factor in this business. The
fact that the Company's textile inks are solvent free and non-polluting makes
its products, in management's view, more desirable than those of its
competitors.
5
<PAGE>
ENVIRONMENTAL CONSIDERATION
The Company does not believe that its operations are adversely affected by
existing environmental regulations. The Company's primary waste products are
non-toxic and non-corrosive such as wood, paper and cardboard and are disposed
of by a private sanitation company. The small amount of chemicals that the
Company disposes of are sealed in non-corrosive containers and are removed from
the premises by a company that disposes of corrosive waste.
PATENTS
The Company's President and other employees of the Company have assigned a total
of 16 United States patents to the Company, 9 of which have expired. The
assigned patents, which cover the basic grafting process, were issued between
1968 and 1996. Each patent is effective for 17 years from the date of its
issuance.
Management can give no assurance that any of the patents which the Company
possesses or might possess in the future, will be enforceable or, if
enforceable, will provide the Company or the holder thereof with an advantage
over its competitors.
ITEM 2. PROPERTY
The Company's offices, research and development and manufacturing facilities are
located in a 64,000 square foot three-story building at 2186 Mill Avenue,
Brooklyn, New York. On June 4, 1990, the Company purchased the building and
adjoining property. The Company had previously leased this facility under the
terms of a long-term operating lease. The purchase price of the property was
$3,000,000 of which the Company paid $500,000 and granted a $2,500,000
seller-financed mortgage, which was renegotiated during 1996. Under the terms of
the renegotiated mortgage the Company made an $800,000 principal installment and
paid a $45,000 renegotiation fee.
(See Note 6 of Notes to Financial Statements).
The Company utilizes the space in the following manner: approximately 11,000
square feet is devoted to office space; approximately 10,000 square feet is
devoted to production of items resulting from research and textile inks;
approximately 35,000 square feet is devoted to research and laboratory
facilities and 8,000 square feet is devoted to warehousing inventory.
The Company believes that its facility is adequate for its current needs and
those of the foreseeable future.
6
<PAGE>
ITEM 3. LEGAL PROCEEDINGS
The Company is a defendant in certain lawsuits which arose in the normal course
of the Company's business. In the opinion of management, should these cases be
adversely determined, the allowance the Company has provided is sufficient to
cover the potential damages on these suits, and they will not have a material
adverse effect on the Company.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
During the fourth quarter of 1996, no matters were submitted to a vote of the
Company's security holders.
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
SHAREHOLDER MATTERS
Since the third quarter of 1990, the Company's Common Stock has traded on the
National Association of Securities Dealers Automated Quotation System ("NASDAQ")
small capital market. The following table sets forth the high and low bid prices
for the periods indicated where the Common Stock is traded under the symbol
PROA. The indicated prices are interdealer prices without retail markups,
markdowns or commissions and do not necessarily represent actual sales. The
limited amount of sales within these ranges should not be interpreted to
indicate that an established trading market exists for the shares of Common
Stock, nor do these prices necessarily accurately reflect the true value of such
shares. The prices indicated have not been adjusted for stock dividends and
stock splits referred to below.
Bid Prices
----------
Quarter LOW HIGH
------- --- ----
1996
October - December 2 2-5/8
July - September 2-5/16 3-1/4
April - June 3-5/8 5-1/4
January - March 3-5/8 4-3/4
1995
October - December 3 5-1/8
July - September 4-5/8 7-5/8
April - June 2-13/64 9-13/32
January - March 2-5/8 3-3/8
1994
October - December 2-3/4 3-1/2
July - September 2-1/4 3-1/8
April - June 2-5/8 3-3/4
January - March 3 4
7
<PAGE>
DIVIDEND POLICY
The Company has paid no cash dividends to its stockholders since its
incorporation and has no present intention to do so. The payment of dividends in
the future will be determined by the Board of Directors based on the Company's
earnings, financial condition, capital requirements and other factors at the
time.
On March 1, 1996 the Company declared a 10% stock dividend to shareholders at
March 15, 1996, paid March 29, 1996. The transaction was valued based upon the
closing market price of the Company's stock on the day prior to declaration (See
Note 9 of Notes to Financial Statements).
On February 21, 1995 the Company declared a 10% stock dividend to shareholders
at March 6, 1995, paid March 20, 1995. The transaction was valued based upon the
closing market price of the Company's stock on the day prior to the declaration.
(See Note 9 of Notes to Financial Statements).
On June 6, 1995 the Company declared a 5 for 4 stock split effected in the form
of a 25% stock dividend, to its shareholders at June 19, 1995 and distributed
June 27, 1995. (See Note 10 of Notes to Financial Statements).
On July 20, 1995 the Company adopted a Shareholders Rights Plan. The Rights Plan
provides for the issuance of one stock right, entitling the holder to buy one
share of common stock at a price of $25 (subject to adjustment, for each
outstanding share of the Company's common stock. The rights will become
excessible only if an "acquiring party" (as defined) acquires or announces a
tender offer to acquire 15% or more of the Company's common stock. The rights
expire July 31, 2005 (See Note 11 of Notes to Financial Statements).
On January 18, 1994 the Company declared a 10% stock dividend to shareholders at
January 31, 1994, paid February 22, 1994. The transaction was valued based upon
the closing market price of the Company's stock on the day prior to the
declaration. (See Note 9 of Notes to Financial Statements).
As of February 18, 1997 there were 1,397,820 shares outstanding, which were held
by 400 shareholders of record.
8
<PAGE>
ITEM 7. MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
RESULTS OF OPERATIONS
Revenue Analysis
Year Ended December 31,
-----------------------
Percentage of
($ In Thousands) Total Revenues
--------------
1996 1995 1994 1996 1995 1994
----- ---- ------ ---- ---- ----
Research $4,326 $4,608 $4,392 85.0% 89.0% 91.4%
Production 752 571 413 15.0 11.0 8.6
------ ------ ------ ----- ----- -----
Total revenues $5,078 $5,179 $4,805 100.0% 100.0% 100.0%
====== ====== ====== ===== ===== =====
1996 v. 1995
Total revenues decreased $101,000 or 2% from $5,179,000 in 1995 to $5,078,000 in
1996. Research revenues decreased 6% while production revenue increased $181,000
or 32.0% from 1995 to 1996.
The decrease in research revenue was primarily attributable to turnover of
personnel. During the latter part of 1995 and early 1996 several important sales
department people left the Company. Their replacements were unable to offset the
decrease in revenue generated by these former employees.
The increase in production sales was primarily the result of increased demand
resulting from research findings for customers in prior years and increased
demand from the industry for polymer coatings.
The rate of inflation has not had a material impact upon the results of
operations.
1995 v 1994
Total revenues increased $374,000 or 8% from $4,805,000 in 1994 to $5,179,000 in
1995. The increase in research revenue accounted for 58% of the increase in
revenue as production revenue increased $158,000 or 38.3% from 1994 to 1995. The
increase was primarily attributable to the continuing strong marketing
activities in recent years, increased demand for research over the last year as
well as continued expansion of the Company's reputation in the industry because
of its technical abilities. The rate of inflation has not had a material impact
upon the results of operations.
9
<PAGE>
Cost of Revenues Analysis
Year Ended December 31,
-----------------------
Percentage of
($ In Thousands) Total Revenues
--------------
1996 1995 1994 1996 1995 1994
---- ---- ---- ---- ---- ----
Research $1,017 $1,311 $1,187 20.0% 25.3% 24.7%
Production 623 505 392 12.3 9.8 8.2
------ ------ ------ ----- ----- ----
Total cost of
revenues $1,640 $1,816 $1,579 32.3% 35.1% 32.9%
====== ====== ====== ===== ===== =====
The cost of research revenues for 1995 and 1994, set forth above, have been
adjusted to exclude sales salaries, which have been reclassified to selling,
general and administrative expenses.
1996 V 1995
Costs of revenues as a percentage of sales decreased from 35.1% in 1995 to 32.3%
in 1996. The primary cause is decreased labor costs.
1995 V 1994
Costs of revenues as a percentage of sales increased slightly from 32.9% in 1994
to 35.1% in 1995. The primary cause is increased labor costs.
Selling, General and Administrative Expenses Analysis
Year Ended December 31,
-----------------------
Percentage of
($ In Thousands) Total Revenues
--------------
1996 1995 1994 1996 1995 1994
---- ---- ---- ---- ---- ----
Selling, General
& Administrative
Expenses $2,681 $2,451 $2,297 52.8% 47.3% 47.8%
====== ====== ====== ===== ===== =====
Selling, general and administrative expenses for 1995 and 1994, set forth above,
have been adjusted to include sales salaries, which were previously charged to
costs of research revenues.
1996 V 1995
Selling, general and administrative expenses, as a percentage of sales,
increased to 52.8% in 1996, as compared to 47.3% during 1995. The increase is
attributed to increased support salaries and related expenses, increased
insurance costs, and increased travel expenses.
10
<PAGE>
1995 V 1994
Selling, general and administrative expenses, as a percentage of sales,
decreased slightly to 47.3% in 1995, as compared to 47.8% during 1994. The
increase is attributed to increased officer salaries and related expenses to
support the additional volume, increased professional fees and increases in
selling expenses.
Income Taxes
1996 V 1995
A total of $158,000 was provided for income taxes for 1996 as compared to
$359,000 in 1995. The provision for income taxes in 1996 and 1995 were
calculated based on the statutory federal income tax rate of 34% plus state and
local taxes. (See Note 12 of Notes to Financial Statements).
1995 v 1994
A total of $359,000 was provided for income taxes for 1995 as compared to
$290,000 in 1994. The provision for income taxes in 1995 and 1994 were
calculated based on the statutory federal income tax rate of 34% plus state and
local taxes. (See Note 12 of Notes to Financial Statements).
CAPITAL RESOURCES AND LIQUIDITY
During 1996, 1995 and 1994, the Company had net cash provided by operating
activities of $393,000, $608,000 and $184,000, respectively. During 1996, 1995
and 1994 the Company used $275,000, $774,000 and $771,000 to purchase
investments, consisting of mutual bond funds and certificate of deposits. In
addition the Company used $18,000, $41,000 and $157,000 to acquire property and
equipment during 1996, 1995 and 1994, respectively. During 1996, 1995 and 1994
the Company made principal payments on long-term debt aggregating $831,000,
$32,000 and $35,000, respectively. The principal payments for 1996 includes an
$800,000 principal installment paid in connection with the mortgage
renegotiation. (See Note 6 of Notes to Financial Statements).
Cash has decreased from $1,474,034 at December 31, 1995 to $709,170 at December
31, 1996. (See the statement of cash flows for a more detailed analysis of
opening versus closing cash).
Cash is generated and used by the Company through its operations. Neither the
issuance of stock nor the acquisition of debt was in 1996, nor expected to be in
1997, significant sources of cash.
11
<PAGE>
In an attempt to secure a better, yet safe, return on excess cash, management
has elected to invest certain cash amounts in marketable securities. These
securities include U.S. Government and New York State Mutual Bond Funds. The
Company closely monitors these investments which are subject to price
fluctuation (See Note 2 to Financial Statements).
There are no known demands for cash related to capital expenditures seen as
imminent in the upcoming three years based on stable sales. Capital expenditures
anticipated in the next year are anticipated to approximate those in the past
three years (see above).
The Company's cash position at December 31, 1996 is deemed sufficient to cover
any unforeseen sales downturn as it is equal to approximately 3 months of
selling, general and administrative expenses. Over both the long and short term,
liquidity will be the direct result of sales.
The ratio of current assets to current liabilities at December 31, 1996 was 2.41
to 1.0 as compared to 4.26 to 1.0 at December 31, 1995.
GENERAL DISCUSSION
Cash flow of the Company is a direct result of net income and net cash provided
from operating activities. Credit extended by the Company in the form of
receivables and received in the form of payables has not had and will not have a
significant impact on cash flow.
Cash flow from financing and investing activities is not expected to have an
impact on cash flow in the next 1 to 3 years. However, the Company is preparing
for the building mortgage balloon payment due on June 1, 2000 related to the
building mortgage (see Note 6 of Notes to the Financial Statements). Management
intends to provide for this payment by accumulating cash prior to the payment
due date.
It is the intent of management to continue on the steady course direction of
recent years which includes steadily increasing research sales yielding
sufficient cash flow to fund operations and provide funds for the future balloon
payment due on the building mortgage and very little in the way of balance sheet
asset or liability increases which will use or provide cash.
No significant changes to operating expenses are anticipated within the next 1
to 3 years.
12
<PAGE>
SEGMENT DISCUSSION
The Company is primarily in the business of research sales. The sale of textile
inks and chemical products is an accommodation to research customers and is not
seen as a segment that could stand on its own as an independent business.
Availability of production of research breakthroughs is an important marketing
tool of the Company to its research customers. No significant capital
expenditures are foreseen in the next 1 to 3 years as necessary for the
continued production of textile inks and chemical products, including potential
increases in such production.
ANALYTIC REVIEW OF QUARTERLY RESULTS
Total revenue for the fourth quarter decreased substantially from the average of
the prior three quarters. However, the Company entered into many new contracts
during the month of December, 1996 resulting in the Company reporting deferred
revenue of $393,300 at December 31, 1996. Deferred revenue represents research
revenue received but not yet earned.
Other income and expenses were significantly higher in the fourth quarter
principally as a result of legal settlements provided for during the quarter. In
addition there were normal year end expenses including bonuses and holiday
expenses as well as legal, travel, and entertainment expenses in connection with
increased year-end selling efforts.
3/31/96 6/30/96 9/30/96 12/31/96
------- ------- ------- --------
Total revenue $1,315,557 $1,359,253 $1,442,155 $ 961,604
Cost of revenue 479,508 471,333 372,432 317,507
Gross profit 836,049 887,920 1,069,723 644,097
SG&A expenses 634,867 682,227 689,668 673,743
Income (loss)
from operations 201,182 205,693 380,055 (29,646)
Other expenses (45,617) (48,360) (91,874) (243,908)
Pre-tax income
(loss) 155,565 157,333 288,181 (273,554)
Income tax expense
(benefit) 75,500 78,000 134,500 (130,303)
Net income (loss) 80,065 79,333 153,681 (143,251)
During the years ended 1996, 1995 and 1994, the quarterly financial statements
reflected a charge for an annualized profit sharing contribution of $100,000.
Such amount is paid in the subsequent year and is included in accrued expenses.
13
<PAGE>
POLYMER RESEARCH CORP.
OF AMERICA
FINANCIAL STATEMENTS
DECEMBER 31, 1996 AND 1995
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
CONTENTS
Page
Independent Auditors' Report F-1
Financial Statements
Balance Sheets at December 31, 1996
and 1995 F-2 - F-3
Statements of Income for the Years Ended
December 31, 1996, 1995 and 1994 F-4
Statement of Changes in Stockholders' Equity
for the Years Ended December 31, 1996, 1995
and 1994 F-5
Statements of Cash Flows for the Years Ended
December 31, 1996, 1995 and 1994 F-6 - F-7
Notes to Financial Statements F-8 - F-19
Financial Statement Schedules
For the Years Ended December 31, 1996, 1995 and 1994:
Report of Independent Certified Public
Accountants on Financial Statement Schedules F-20
VIII Valuation and Qualifying Accounts and Reserves F-21
X Supplementary Income Statement Information F-22
XI Property, Equipment and Accumulated Depreciation F-23
All other schedules have been omitted because the required information
is included in the financial statements or the notes thereto or because they are
not required.
<PAGE>
[LETTERHEAD]
INDEPENDENT AUDITORS' REPORT
To The Stockholders and Board of Directors
Polymer Research Corp. of America
Brooklyn, New York
We have audited the accompanying balance sheets of Polymer Research Corp. of
America at December 31, 1996 and 1995, and the related statements of income,
stockholders' equity and cash flows for the years ended December 31, 1996, 1995
and 1994. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Polymer Research Corp. of
America at December 31, 1996 and 1995 and the results of its operations and its
cash flows for the years ended December 31, 1996, 1995 and 1994, in conformity
with generally accepted accounting principles.
/s/ Castellano, Korenberg & Co. CPAs, P.C.
---------------------------------------------------
CASTELLANO, KORENBERG & CO. CPAs, P.C.
Westbury, New York
February 18, 1997
F-1
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
BALANCE SHEETS
DECEMBER 31, 1996 AND 1995
ASSETS
1996 1995
---- ----
CURRENT ASSETS:
Cash $ 709,170 $1,474,034
Certificates of deposit 554,338 142,611
Investment securities available
for sale 473,283 588,481
Accounts receivable, less allowance for
doubtful accounts of $-0- for 1996
and $4,000 for 1995 91,850 59,816
Inventories 85,822 72,713
Prepaid income taxes 167,000 -0-
Prepaid expenses and other current assets 28,086 12,595
---------- ----------
Total Current Assets 2,109,549 2,350,250
---------- ----------
PROPERTY AND EQUIPMENT 2,939,514 3,014,588
---------- ----------
OTHER ASSETS:
Deferred financing costs, less
accumulated amortization of $2,728 for
1996 and $2,366 for 1995 11,814 12,177
---------- ----------
$5,060,877 $5,377,015
========== ==========
See independent auditors' report and notes to financial statements.
F-2
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
BALANCE SHEETS
DECEMBER 31, 1996 AND 1995
LIABILITIES AND STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
1996 1995
---- ----
CURRENT LIABILITIES:
<S> <C> <C>
Current maturities of long-term debt $ 28,143 $ 39,146
Accounts payable 56,907 13,142
Deferred revenue 393,300 170,837
Income taxes payable -0- 33,400
Accrued expenses and other current
liabilities 417,714 295,083
---------- ----------
Total Current Liabilities 896,064 551,608
---------- ----------
LONG-TERM LIABILITY:
Long-term debt, less current maturities 1,483,080 2,303,355
---------- ----------
STOCKHOLDERS' EQUITY:
Common stock - $.01 par value; 4,000,000 shares authorized; 1,489,657 and
1,354,234 shares issued at December 31, 1996 and
1995 respectively 14,896 13,542
Capital in excess of par value 2,632,037 2,091,699
Retained earnings 103,654 475,518
Unrealized holding losses (12,117) (1,970)
---------- ----------
2,738,470 2,578,789
Less: Treasury stock, at cost - 91,837
shares in 1996 and 83,488 shares
in 1995 56,737 56,737
---------- ----------
Total Stockholders' Equity 2,681,733 2,522,052
---------- ----------
$5,060,877 $5,377,015
========== ==========
</TABLE>
See independent auditors' report and notes to financial statements.
F-3
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
STATEMENTS OF INCOME
FOR THE YEARS ENDED DECEMBER 31, 1996, 1995 AND 1994
<TABLE>
<CAPTION>
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
NET REVENUES:
Research $4,326,424 $4,607,889 4,391,701
Production 752,145 571,256 412,693
---------- ---------- ----------
5,078,569 5,179,145 4,804,394
---------- ---------- ----------
COST OF REVENUES:
Research 1,017,460 1,310,643 1,186,968
Production 623,320 504,621 392,421
---------- ---------- ----------
1,640,780 1,815,264 1,579,389
---------- ---------- ----------
GROSS PROFIT 3,437,789 3,363,881 3,225,005
SELLING, GENERAL AND ADMINISTRATIVE
EXPENSES 2,680,505 2,450,509 2,297,423
---------- ---------- ----------
INCOME FROM OPERATIONS 757,284 913,372 927,582
---------- ---------- ----------
OTHER INCOME (EXPENSE):
Interest income 58,965 55,358 44,363
Interest expense (227,683) (227,195) (272,452)
Net rental income (expense) 2,850 5,000 (26,384)
Litigation settlements (217,270) (40,641) (33,773)
Loss on disposition of property
and equipment -0- -0- (13,762)
Realized gain (loss) on investment
in marketable securities (1,621) 9,890 (3,779)
---------- ---------- ----------
Mortgage modification expense (45,000) -0- -0-
---------- ---------- ----------
Total Other Expense (429,759) (197,588) (305,787)
---------- ---------- ----------
INCOME BEFORE PROVISION FOR INCOME
TAXES 327,525 715,784 621,795
PROVISION FOR INCOME TAXES 157,697 358,841 290,397
---------- ---------- ----------
NET INCOME $ 169,828 $ 356,943 $ 331,398
========== ========== ==========
EARNINGS PER SHARE $ .12 $ .26* $ .24**
========== ========== ==========
WEIGHTED AVERAGE NUMBER OF SHARES
OUTSTANDING 1,397,820 1,397,820* 1,398,634**
========== ========== ==========
</TABLE>
* Restated for 1996 10% stock dividend
** Restated for 1996 10% stock dividend and
1995 10% stock dividend and 5 for 4 stock split
See independent auditors' report and notes to financial statements.
F-4
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
FOR THE YEARS ENDED DECEMBER 31, 1996, 1995 AND 1994
<TABLE>
<CAPTION>
Common Stock, $.01 Par
Value Authorized;
4,000,000 Shares Capital Unrealized Treasury Stock - At Cost
----------------------- in Excess Retained Holding ------------------------
Shares Amount of Par Earnings Losses Shares Amount
------ ------ ------ -------- ------ ------ ------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
BALANCE, DECEMBER 31, 1993 895,319 $ 8,953 $ 1,484,587 $ 398,878 $ -0- 53,839 $ (52,286)
STOCK DIVIDEND 89,578 896 312,627 (313,523) -0- 5,384 -0-
PURCHASE OF TREASURY STOCK -0- -0- -0- -0- -0- 1,496 (4,451)
UNREALIZED LOSS ON
INVESTMENT SECURITIES
AVAILABLE FOR SALE -0- -0- -0- -0- (27,198) -0- -0-
NET INCOME -0- -0- -0- 331,398 -0- -0- -0-
---------- ---------- ----------- ----------- --------- ---------- ----------
BALANCE, DECEMBER 31, 1994 984,897 9,849 1,797,214 416,753 (27,198) 60,719 (56,737)
STOCK DIVIDEND 98,490 985 294,485 (295,470) -0- 6,072 -0-
STOCK SPLIT 270,847 2,708 -0- (2,708) -0- 16,697 -0-
UNREALIZED GAIN ON
INVESTMENT SECURITIES
AVAILABLE FOR SALE -0- -0- -0- -0- 25,228 -0- -0-
NET INCOME -0- -0- -0- 356,943 -0- -0- -0-
---------- ---------- ----------- ----------- --------- ---------- ----------
BALANCE, DECEMBER 31, 1995 1,354,234 13,542 2,091,699 475,518 (1,970) 83,488 (56,737)
STOCK DIVIDEND 135,423 1,354 540,338 (541,692) -0- 8,349 -0-
UNREALIZED LOSS ON
INVESTMENT SECURITIES
AVAILABLE FOR SALE -0- -0- -0- -0- (10,147) -0- -0-
NET INCOME -0- -0- -0- 169,828 -0- -0- -0-
---------- ---------- ----------- ----------- --------- ---------- ----------
BALANCE DECEMBER 31, 1996 1,489,657 $ 14,896 $ 2,632,037 $ 103,654 $ (12,117) 91,837 $ (56,737)
========= ========== =========== =========== ========= ========== ==========
</TABLE>
See independent auditors' report and notes to financial statements.
F-5
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1996, 1995 AND 1994
<TABLE>
<CAPTION>
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers $5,266,656 $5,260,240 $4,753,698
Interest received 58,965 55,358 44,363
Rent received 2,850 5,000 20,200
---------- ---------- ----------
Cash Provided By Operating
Activities 5,328,471 5,320,598 4,818,261
---------- ---------- ----------
Cash paid for merchandise (1,572,608) (1,752,829) (1,566,462)
Cash paid to suppliers and
employees (2,585,381) (2,354,309) (2,321,280)
Interest paid (227,683) (227,195) (272,452)
Income taxes paid (358,097) (348,556) (450,955)
Cash paid for litigation
settlement (146,770) (30,141) (23,273)
Mortgage modification fee paid (45,000) -0- -0-
---------- ---------- ----------
Cash Disbursed For Operating
Activities (4,935,539) (4,713,027) (4,634,422)
---------- ---------- ----------
NET CASH PROVIDED BY
OPERATING ACTIVITIES 392,932 607,571 183,839
---------- ---------- ----------
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturity of
certificates of deposit 142,611 136,086 49,948
Proceeds from sale of marketable
securities 378,619 807,290 589,606
---------- ---------- ----------
Cash Provided By Investing
Activities 521,230 943,376 639,554
---------- ---------- ----------
Purchase of certificates of
deposits (554,338) (142,611) -0-
Purchase of marketable securities (275,189) (773,517) (771,386)
Purchase of property and equipment (18,221) (41,445) (156,681)
---------- ---------- ----------
Cash Disbursed For Investing
Activities (847,748) (957,573) (928,067)
---------- ---------- ----------
NET CASH USED IN INVESTING
ACTIVITIES (326,518) (14,197) (288,513)
---------- ---------- ---------
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term
borrowings (831,278) (32,460) (34,560)
Purchase of treasury stock -0- -0- (4,451)
---------- ---------- ----------
NET CASH USED IN FINANCING
ACTIVITIES (831,278) (32,460) (39,011)
---------- ---------- ----------
NET INCREASE (DECREASE) IN
CASH (764,864) 560,914 (143,685)
CASH, BEGINNING OF YEAR 1,474,034 913,120 1,056,805
---------- ---------- ----------
CASH, END OF YEAR $ 709,170 $1,474,034 $ 913,120
========== ========== ==========
</TABLE>
See independent auditors' report and notes to financial statements.
F-6
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED DECEMBER 31, 1996, 1995 AND 1994
<TABLE>
<CAPTION>
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
RECONCILIATION OF NET INCOME TO NET CASH
PROVIDED BY OPERATING ACTIVITIES:
NET INCOME $ 169,828 $ 356,943 $ 331,398
---------- ---------- ----------
ADJUSTMENTS TO RECONCILE NET INCOME TO
NET CASH PROVIDED BY OPERATING ACTIVITIES:
Loss on disposition of property
and equipment -0- -0- 13,762
Depreciation and amortization 93,658 103,824 99,052
Bad debt expense 2,342 6,255 3,328
Realized (gain) loss on investment
in marketable securities 1,621 (9,890) 3,779
Changes in assets (increase) decrease:
Accounts receivable (34,376) (6,026) (37,696)
Inventories (13,109) (1,043) 282
Prepaid income taxes (167,000) -0- -0-
Prepaid expenses and other current
assets (15,491) 41,699 (43,164)
Other assets -0- 8,199 9,774
Changes in liabilities increase (decrease):
Accounts payable 43,765 (8,111) (17,640)
Deferred revenue 222,463 85,837 (13,000)
Income taxes payable (33,400) 10,275 (160,558)
Accrued expenses and other current
liabilities 122,631 19,609 (5,478)
---------- ---------- ----------
Total Adjustments 223,104 250,628 (147,559)
---------- ---------- ----------
NET CASH PROVIDED BY
OPERATING ACTIVITIES $ 392,932 $ 607,571 $ 183,839
========== ========== ==========
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock dividend paid $ 1,354 $ 985 $ 896
========== ========== ==========
Stock split paid $ -0- $ 2,708 $ -0-
========== ========== ==========
Unrealized gain (loss) on
investment securities $ (10,147) $ 25,228 $ (27,198)
========== ========== ==========
</TABLE>
See independent auditors' report and notes to financial statements.
F-7
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 1 - Summary of Significant Accounting Policies
Business Activity
Polymer Research Corp. of America ("The Company") is an
international research concern. The Company is predominately
engaged in the research and development of the applications of
chemical grafting. Secondarily, the Company produces and sells
products arising from research activities and textile printing
inks. Revenue for research and production is derived from
various manufacturers throughout the United States and
worldwide.
Credit Risk
Financial instruments that potentially subject the Company to
credit risk include investments in United States Treasury bills,
notes and other certificates of deposit, government agencies'
securities and U.S. Government and New York State mutual bond
funds. Future changes in economic conditions may make the
investments less valuable.
In addition, financial instruments that potentially subject the
Company to credit risk also include accounts receivable.
Accounts receivable resulting from product sales are not
collateralized. The Company maintains deposits with financial
institutions in excess of amounts insured by the FDIC.
Pervasiveness of Estimates
The preparation of financial statements in conformity with
generally accepted accounting principles requires management to
make estimates and assumptions that affect reported amounts of
assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates.
F-8
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 1 - Summary of Significant Accounting Policies (cont'd)
Revenue Recognition
Revenue from research contracts is recognized based upon two
criteria: first, client approval of performance of specific
stage of the contract and second, collection of the resulting
revenue is assured. Revenue from production is recognized when
the product is shipped for sale to customers.
Cash Equivalents
The Company considers securities with maturities of three months
or less, when purchased, to be cash equivalents.
Investment Securities
The Company determines the appropriate classification of
securities at the time of purchase. If the Company has the
intent and the ability at the time of purchase to hold
securities until maturity or on a long-term basis, they are
classified as investment securities and carried at amortized
historical cost. Securities to be held for indefinite periods of
time and not intended to be held to maturity or on a long-term
basis are classified as available for sale and carried at fair
value. Securities held for indefinite periods of time include
securities that management intends to use as part of its asset
and liability management strategy and that may be sold in
response to changes in interest rates, resultant prepayment risk
and other factors related to interest rate and resultant
prepayment risk changes.
Realized gains and losses on dispositions are based on the net
proceeds and the adjusted book value of the securities sold,
using the specific identification method. Unrealized gains and
losses on investment securities available for sale are based on
the difference between book value and fair value of each
security. These gains and losses are credited or charged to
shareholders' equity, whereas realized gains and losses flow
through the Company's yearly operations.
F-9
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 1 - Summary of Significant Accounting Policies (cont'd)
Inventories
Inventories, which consists of raw materials and finished goods
is valued at the lower of cost or market, with cost determined
using the first-in, first-out method and with market defined as
the lower of replacement cost or realizable value.
Property and Equipment
Property and equipment is stated at cost. The costs of additions
and betterments are capitalized and expenditures for repairs and
maintenance are expensed in the period incurred. When items of
property and equipment are sold or retired, the related costs
and accumulated depreciation are removed from the accounts and
any gain or loss is included in income.
The Company capitalizes leased equipment where the terms of the
lease result in the transfer to the Company of substantially all
of the benefits and risks of ownership of the equipment.
Depreciation and amortization of property and equipment is
provided utilizing both the straight-line and accelerated
methods over the estimated useful lives of the respective assets
as follows:
Building and building
improvements 40 years
Land improvements 20 years
Transportation equipment 3 to 5 years
Machinery and equipment 5 years
Furniture and fixtures 5 to 10 years
Office equipment 5 years
Deferred Financing Costs
Costs incurred in obtaining the mortgage used to finance the
purchase of its building have been capitalized and are being
amortized over the term of the related obligation utilizing the
straight-line method.
Deferred Revenue
The Company records as deferred revenue payments received from
research contracts prior to the culmination of the revenue
process.
F-10
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 1 - Summary of Significant Accounting Policies (cont'd).
Income Taxes
The Company accounts for its income taxes utilizing Statement of
Financial Accounting Standards ("SFAS") No. 109 "Accounting for
Income Taxes" which requires that the Company follow the
liability method of accounting for income taxes.
The liability method provides that deferred tax assets and
liabilities are recorded based on the difference between the tax
bases of assets and liabilities and their carrying amounts for
financial reporting purposes, referred to as "temporary
differences." The adoption of the new standard did not have a
material impact on the Company's financial position or results
of operations.
Profit Sharing Plan
The Company maintains a qualified noncontributory profit sharing
plan. The plan provides all eligible employees with a source of
retirement income, as well as assistance in other circumstances
such as death or disability. Eligible employees must meet two
requirements to become participants; attainment of age 21 and
completion of one year of service with the Company. Employer
contributions are determined by an annual resolution of the
Board of Directors. A percentage of the benefits vest after
three years of qualifying service.
Earnings Per Share
Earnings per share is computed based upon the weighted average
number of common shares outstanding during each year.
Reclassifications
Certain accounts relating to the prior years have been
reclassified to conform to the current year's presentation.
These reclassifications have no effect on previously reported
income.
F-11
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 2 - Investment Securities
At December 31, 1996 and 1995, the investment securities
portfolio is comprised of securities classified as available for
sale, in conjunction with the adoption of FASB 115, resulting in
investment securities available for sale being carried at market
value.
The amortized cost and fair values of investment securities
available for sale at December 31, 1996 are:
Gross Gross
Amortized Unrealized Unrealized Fair
Cost Gains Losses Value
--------- ---------- --------- ---------
U.S. Treasury
securities $ 148,367 $ -0- $ (2,332) $ 146,035
Obligations of
other U.S.
government
agencies 194,572 -0- (9,407) 185,165
Other securities 149,999 -0- (7,916) 142,083
--------- ---------- --------- ---------
$ 492,938 $ -0- $ (19,655) $ 473,283
========= ========== ========= =========
The amortized cost and fair values of investment securities
available for sale at December 31, 1995 are:
Gross Gross
Amortized Unrealized Unrealized Fair
Cost Gains Losses Value
--------- ---------- --------- ---------
U.S. Treasury
securities $ 104,239 $ 2,221 $ -0- $ 106,460
Obligations of
other U.S.
government
agencies 344,400 1,038 (7,139) 338,299
Other securities 149,999 -0- (6,277) 143,722
--------- ---------- --------- ---------
$ 598,638 $ 3,259 $ (13,416) $ 588,481
========= ========== ========= =========
The amortized cost and fair values of investment securities
available for sale December 31, 1996 by expected maturity are
shown below. Expected maturities will differ from contractual
maturities because borrowers may have the right to call or
prepay obligations with or without call or prepayment penalties.
F-12
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 2 - Investment Securities (cont'd)
Securities Available
For Sale
-------------------------
Amortized Fair
Cost Value
--------- --------
Due in one year or less $ 3,956 $ 3,750
Due after one year but less
than five years 55,705 55,457
Due after five years but
less than ten years 36,671 35,874
Due after ten years 52,035 50,954
--------- --------
148,367 146,035
Mortgage-backed securities 194,572 185,165
Other securities 149,999 142,083
-------- --------
$492,938 $473,283
======== ========
Proceeds from sales and maturities of investment securities
available for sale during 1996 and 1995 were $258,279 and
$751,163, respectively. Gross gains on 1996 sales and maturities
were $578. Gross losses on 1995 sales and maturities were
$4,026. Included in shareholders' equity at December 31, 1996
and 1995 is $12,117 and $1,970 respectively, of net unrealized
losses on investment securities available for sale.
Note 3 - Inventories
Inventories at December 31, 1996 and 1995 are as follows:
1996 1995
---- ----
Raw materials $ 73,515 $ 57,087
Finished goods 12,307 15,626
---------- ----------
$ 85,822 $ 72,713
========== ==========
F-13
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 4 - Property and Equipment
Property and equipment is summarized as follows:
1996 1995
---- ----
Land $ 450,000 $ 450,000
Land improvements 80,211 80,211
Building 2,550,000 2,550,000
Building improvements 289,505 273,755
Transportation equipment 12,967 12,967
Machinery and equipment 200,259 200,259
Furniture and fixtures 98,213 95,742
Office equipment 60,664 60,664
---------- ----------
3,741,819 3,723,598
Less: Accumulated
depreciation
and amortization 802,305 709,010
---------- ----------
$2,939,514 $3,014,588
========== ==========
Depreciation and amortization expense related to property and
equipment amounted to $93,295, $103,824 and $99,052 for the
years ended December 31, 1996, 1995 and 1994 respectively.
Note 5 - Deferred Revenue
At December 31, 1996 and 1995 the Company had received research
contract payments not yet earned aggregating $393,300 and
$170,837, respectively.
Note 6 - Mortgage Payable
On August 20, 1996 the Company renegotiated the mortgage on its
building. The terms of the agreement required the Company to
make an $800,000 principal installment and pay a renegotiation
fee of $45,000. The remaining balance of the mortgage is being
paid pursuant to a 25-year amortization in monthly installments
of $15,457 including principal and interest at the rate of
10.50% per annum. The entire unpaid principal balance at the end
of the mortgage term, anticipated to be $1,398,330, is due in a
balloon payment on June 1, 2000.
The mortgage is secured by a lien on the building. The principal
balances payable on the mortgage amounted to $1,511,223 and
$2,342,501 of which $28,143 and $39,146 represent current
maturities of the mortgage at December 31, 1996 and 1995
respectively.
F-14
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 6 - Mortgage Payable (cont'd).
Aggregate maturities of the mortgage note payable are as
follows:
Years Ending December 31:
-------------------------
1997 $ 28,143
1998 31,244
1999 34,688
2000 1,417,148
----------
$1,511,223
==========
Note 7 - Contingencies
At December 31, 1996, the Company is a defendant in various
lawsuits which arose in the ordinary course of business. At
December 31, 1996, the Company has provided $150,000, included
in current liabilities, as a provision for unfavorable findings
and/or settlements in certain of these cases. It is management's
opinion that the ultimate liability, if any, which might result
from the remainder of such actions would not have a material
effect on the Company's financial position.
Note 8 - Commitments
<PAGE>
On July 26, 1994 the Company entered into retirement agreements
with 2 key executives. The agreements set a compensation rate of
60% of the average 5 preceding years' annual compensation,
payable for the remainder of the executive's life. The Company
is also responsible to maintain the executives medical
insurance.
On March 1, 1993 the Company extended its employment contract
with its President which expires on May 16, 1998. The contract
provides for a current minimum annual salary of $160,000 for
1996 and annual increases of $10,000 throughout its duration.
Note 9 - Stock Dividends
On March 1, 1996 the Company declared a 10% stock dividend to
stockholders of record at March 15, 1996, paid March 29, 1996.
The transaction was valued based upon the closing market price
of the Company's stock on March 15, 1996 which was $4.00 per
share. Retained earnings was charged for $541,692 as a result of
the issuance of 135,423 shares.
F-15
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 9 - Stock Dividends (cont'd).
On February 21, 1995 the Company declared a 10% stock dividend
to stockholders of record at March 6, 1995, paid March 20, 1995.
The transaction was valued based upon the closing market price
of the Company's stock on February 21, 1995, which was $3.00 per
share. Retained earnings was charged for $295,470 as a result of
the issuance of 98,490 shares.
On January 18, 1994 the Company declared a 10% stock dividend to
stockholders of record at January 31, 1994, paid February 22,
1994. The transaction was valued based upon the closing market
price of the Company's stock on February 21, 1995 which was
$3.50 per share. Retained earnings was charged for $313,523 as a
result of the issuance of 89,578 shares.
Per share data were retroactively restated for the effects of
the 1996, 1995 and 1994 stock dividends.
Note 10- Stock Split
On June 6, 1995 the Company declared a 5 for 4 stock split
effected in the form of a 25% stock dividend, to stockholders of
record at June 19, 1995, distributed June 27, 1995. As a result
of this transaction, an additional 270,847 shares were issued.
The Company did not distribute fractional shares from the stock
split. The Company's par value of $.01 per share remained
unchanged. Per share data was retroactively restated for the
effects of the stock split.
Note 11- Shareholders Rights Plan
On July 20, 1995, the Company adopted a Shareholders Rights
Plan. The Company adopted the plan to protect shareholders
against unsolicited attempts to acquire control of the Company.
The rights will be issued to shareholders of record on July 31,
1995 and will expire on July 31, 2005. The Rights Plan provides
for the issuance of one stock right for each outstanding share
of the Company's common stock. The rights will become
exercisable only if an "acquiring party" (as defined in the
rights plan) acquires 15% or more of the Company's common stock
F-16
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 11- Shareholder Rights Plan (cont'd)
or announces a tender offer that would result in ownership of
15% or more of the Company's common stock.
Each right will entitle the holder to buy one share of common
stock at an exercise price of $25, subject to adjustment.
Upon the occurrence of certain events, holders of the rights
will be entitled to purchase either the Company's stock or
shares in an "Acquiring Entity" at 50% of those shares market
value.
The Company will generally be entitled to redeem all rights for
$.01 per right at any time prior to the tenth day following the
acquisition of 15% or more of the Company's common stock by a
person or group.
Note 12- Provision For Income Taxes
The provision for income taxes is summarized as follows:
1996 1995 1994
---- ---- ----
Federal $ 92,054 $207,140 $174,824
State and local 65,643 151,701 115,573
-------- -------- --------
Provision for income
taxes $157,697 $358,841 $290,397
======== ======== ========
The reconciliation between the maximum effective income tax
rates with federal statutory tax rates for the year ended
December 31, 1996 and the rates reflected in the accompanying
financial statements is as follows:
Income taxes at U.S. statutory rates $ 111,358
(Decrease) increase in federal income
tax expense resulting from:
Federal tax arising from non-
deductible financial statement
expenses 6,426
Benefit from utilization of lower
federal tax brackets (3,411)
Benefit from deduction for state
and local taxes (22,319)
State and local taxes 65,643
----------
Provision for Income Taxes $ 157,697
==========
F-17
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 13- Industry Segments
The Company's operations are classified into the following two
industry segments:
Research - Providing laboratory research services in the area
of polymer chemistry.
Production - Manufacture and sale of products arising fro
research activities and the sale of textile
printing inks and accessories.
Information on industry segments for the years ended December
31, 1996, 1995 and 1994 are as follows:
<PAGE>
<TABLE>
<CAPTION>
1996 1995 1994
---- ---- ----
<S> <C> <C> <C>
NET REVENUES:
Research $4,326,424 $4,607,889 $4,391,701
Production 752,145 571,256 412,693
---------- ---------- ----------
Total Net Revenues $5,078,569 $5,179,145 $4,804,394
========== ========== ==========
GROSS PROFIT:
Research $3,308,964 $3,297,246 $3,204,733
Production 128,825 66,635 20,272
---------- ---------- ----------
Total Gross Profit 3,437,789 3,363,881 3,225,005
SELLING, GENERAL AND ADMINISTRATIVE
EXPENSES 2,680,505 2,450,509 2,297,423
---------- ---------- ----------
INCOME FROM OPERATIONS $ 757,284 $ 913,372 $ 927,582
========== ========== ==========
CAPITAL EXPENDITURES:
Research $ 3,603 $ 12,189 $ 51,231
Production 2,881 9,747 26,075
Corporate 5,766 19,509 59,819
Rental Allocation -0- -0- 19,556
---------- ---------- ----------
Total $ 12,250 $ 41,445 $ 156,681
========== ========== ==========
DEPRECIATION AND AMORTIZATION:
Research $ 27,545 $ 30,309 $ 16,825
Production 22,028 24,239 13,460
Corporate 44,085 49,276 58,673
Rental allocation -0- -0- 10,094
---------- ---------- ----------
Total $ 93,658 $ 103,824 $ 99,052
========== ========== ==========
</TABLE>
F-18
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
NOTES TO FINANCIAL STATEMENTS
Note 13- Industry Segments (cont'd).
1996 1995 1994
---- ---- ----
IDENTIFIABLE ASSETS:
Research $ 886,238 $ 885,752 $ 776,240
Production 831,529 818,175 707,707
Corporate 3,343,110 3,673,088 2,985,004
Rental allocation -0- -0- 450,743
---------- ---------- ----------
Total $5,060,877 $5,377,015 $4,919,694
========== ========== ==========
Net income from operations represents net sales less operating
expenses for each segment and corporate expenses which are not
directly attributable to any segment. A ratable portion of
corporate expenses have been charged to rental operations.
Segment identifiable assets include accounts receivable,
inventories and property and equipment for use in, or directly
attributable to, the individual segments. Corporate identifiable
assets include cash, property and equipment and other assets
which are not directly attributable to any individual segment.
There was no individual customer from which the Company derived
10% or more of its revenues during the periods presented.
Note 14 - Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities aresummarized
as follows:
1996 1995
---- ----
Accrued profit sharing $ 100,000 $ 100,000
Accrued legal settlements 150,000 79,500
Accrued vacation 25,584 23,513
Accrued professional fees 30,000 30,000
Other items (none in excess
of 5% of total current
liabilities) 112,130 62,070
---------- ----------
$ 417,714 $ 295,083
========== ==========
Note 15 - Profit Sharing Plan
Profit sharing expense under the Company's noncontributory
profit sharing plan charged to operations amounted to $100,000 for the years
ended December 31, 1996, 1995 and 1994.
F-19
<PAGE>
[LETTERHEAD]
To The Stockholders
Polymer Research Corp. of America
Brooklyn, New York
Our report on our audits of the basic financial statements of Polymer Research
Corp. of America for 1996, 1995 and 1994, appears on page F-1. Those audits were
made for the purpose of forming an opinion on the basic financial statements
taken as a whole. The accompanying supplementary information is presented for
the purpose of additional analysis and is not a required part of the basic
financial statements. Such information has been subjected to the auditing
procedures applied in the audit of the basic financial statements and, in our
opinion, is fairly stated in all material respects in relation to the basic
financial statements taken as a whole.
/s/ Castellano, Korenberg & Co., CPAs, P.C.
-------------------------------------------
CASTELLANO, KORENBERG & CO., CPAs, P.C.
Westbury, New York
February 18, 1997
-20-
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
SCHEDULE VIII - VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
<TABLE>
<CAPTION>
Column A Column B Column C Column D Column E
- -------- ---------- ------------------------- ---------- --------
Additions
-------------------------
Balance at Charged to Charged Balance
Beginning Costs and to Other At End
Description of Year Expenses Accounts Deductions of Year
- ----------- ---------- ---------- ---------- ---------- ----------
Allowance for Doubtful Accounts:
<S> <C> <C> <C> <C> <C>
Year ended December 31, 1996 $ 4,000 $ 2,342 $ -0- $ 6,342 $ -0-
---------- ---------- ---------- ---------- ----------
Year ended December 31, 1995 $ -0- $ 6,255 $ -0- $ 2,255 $ 4,000
---------- ---------- ---------- ---------- ----------
Year ended December 31, 1994 $ -0- $ 2,360 $ -0- $ 2,360 $ -0-
---------- ---------- ---------- ---------- ----------
Reserve for Sales Credits:
Year ended December 31, 1996 $ -0- $ -0- $ -0- $ -0- $ -0-
---------- ---------- ---------- ---------- ----------
Year ended December 31, 1995 $ -0- $ -0- $ -0- $ -0- $ -0-
---------- ---------- ---------- ---------- ----------
Year ended December 31, 1994 $ -0- $ -0- $ -0- $ -0- $ -0-
---------- ---------- ---------- ---------- ----------
</TABLE>
F-21
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
SCHEDULE X - SUPPLEMENTARY INCOME STATEMENT INFORMATION
Charged To Costs and Expenses
-----------------------------
December 31,
------------
1996 1995 1994
---- ---- ----
1. MAINTENANCE AND REPAIR $ 56,208 $ * $ 83,269
-------- -------- --------
2. DEPRECIATION $ 93,295 $103,824 $ 99,052
-------- -------- --------
3. TAXES, OTHER THAN PAYROLL
AND INCOME TAXES * * *
4. ROYALTIES * * *
5. ADVERTISING COSTS * * *
Note: * Less than 1% of revenue.
F-22
<PAGE>
POLYMER RESEARCH CORP. OF AMERICA
SCHEDULE XI - PROPERTY, EQUIPMENT AND ACCUMULATED DEPRECIATION
YEAR ENDED DECEMBER 31, 1996
<TABLE>
<CAPTION>
Gross Amount At Which Carried At
Initial Cost to Company Close of Period Life On Which
----------------------- -------------------------------- Depreciation
In Latest
Land Land Income
Building and Building and Accumulated Date Statement
Description Encumbrances Improvements Equipment Improvements Equipment Total Depreciation Acquired is Computed
- ----------- ------------ ------------ --------- ------------ --------- ---------- ------------ ---------- -----------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Land, Building and
Improvements $1,511,223 $3,369,716 $ -0- $3,369,716 $ -0- $3,369,716 $ 640,379 June 4, 1990 20-40 Years
Equipment -0- -0- 372,103 -0- 372,103 372,103 161,926 Various 3-10 Years
---------- ---------- ---------- ---------- ---------- ---------- ----------
$1,511,223 $3,369,716 $ 372,103 $3,369,716 $ 372,103 $3,741,819 $ 802,305
========== ========== ========== ========== ========== ========== ==========
</TABLE>
F-23
<PAGE>
ITEM 9. DISAGREEMENTS ON FINANCIAL AND ACCOUNTING DISCLOSURES
None
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS
The directors and executive officers of the Company as of December 31, 1996 are
as follows:
NAME AGE POSITION
- ---- --- --------
Carl Horowitz 73 President and Director
Irene Horowitz 73 Senior Vice President
and Director
John M. Ryan 41 Director, Executive Vice
President, Corporate
Research
Alice J. Horowitz 37 Director
Boris Jody 77 Director
Anna Dichter 83 Secretary, Treasurer
George V. Sawey 68 Vice President,
Chemicals
Terry J. Wolfgang 35 Director
Dr. Mohan Sanduja, 61 Vice President, R & D
PHD Director
Clare Chamow 62 Vice President, Office
Management
Betty Friedman 65 Vice President, Personnel
Carl Horowitz founded the Company and has devoted his full time and efforts to
the affairs of the Company, as its President and as a Director, since 1963. Mr.
Horowitz received a B.S. in Chemical Engineering at Columbia University in New
York in 1950, and a Master of Science degree in Polymer Chemistry from
Polytechnic Institute of Brooklyn in 1961. Mr. Horowitz is the husband of Irene
Horowitz and the father of Alice J. Horowitz and Terry J. Wolfgang.
14
<PAGE>
Irene Horowitz has been a Director and a Senior Vice President of the Company
since 1980. Mrs. Horowitz devotes her full time and efforts to the affairs of
the Company, and her primary responsibility as Senior Vice President is to
oversee the operations of the Company. Mrs. Horowitz is the wife of Carl
Horowitz and the sister of Anna Dichter and the mother of Alice J. Horowitz and
Terry J. Wolfgang.
John M. Ryan has been a Director since September, 1984. Mr. Ryan has been
employed by the Company since 1981 as a technical director of Special Product
Development and has been the Executive Vice President of Corporate Research
since 1985.
Alice J. Horowitz was a Senior Vice President. In 1987, she became a Director.
During 1995 Ms. Horowitz relocated outside of New York. Ms. Horowitz is the
daughter of Carl and Irene Horowitz.
Boris Jody was elected a Director of the Company in 1984. Mr. Jody is currently
retired. Mr. Jody previously was with Standard Motor Products, Inc., where he
had been Vice President of Corporate Affairs.
Anna Dichter joined the Company in 1968 as Controller. She was elected
Secretary/Treasurer of the Company in 1977. Mrs. Dichter, who devotes her full
time and efforts to the affairs of the Company, is in charge of maintaining the
Company's books on a day-to-day basis. She is the sister of Irene Horowitz.
George V. Sawey has been employed full time by the Company since 1972 and is
Vice President in charge of chemical products. He is responsible for the
manufacture of textile inks and chemical products resulting from research.
Terry J. Wolfgang has been a Director of the Company since 1989. She has been
engaged in the private practice of law in New York City. Ms. Wolfgang is the
daughter of Carl and Irene Horowitz. Ms. Wolfgang and law firms with whom she
has been associated occasionally have performed legal services for the Company.
Payments in 1996, 1995 and 1994 amounted to $43,873, $16,664, and $31,227
respectively.
Dr. Mohan Sanduja, PHD joined the Company in 1979 as Assistant Director of
Research. In 1982, he became a Director of Research and Development. In 1987, he
became a Director of the Company and Vice President of Research and Development.
15
<PAGE>
Clare Chamow joined the Company in 1982. She became a Vice President in March of
1996 and is responsible for office management. She is a graduate of Brooklyn
College with a B.A. Degree in Education.
Betty Friedman joined the Company in 1976. She became a Vice President in March
of 1996 and is in charge of personnel and purchasing for production.
16
<PAGE>
ITEM 11. EXECUTIVE COMPENSATION
The following table sets forth the compensation paid during the uears ended
December 31, 1996, 1995 and 1994 to the chief executive officer and those three
executive officers of the Company who earned in excess of $100,000 for the year
ended December 31, 1996.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
LONG TERM COMPENSATION
----------------------
ANNUAL COMPENSATION AWARDS PAYOUTS
-------------------------------------------------------------------------------
(a) (b) (c) (d) (e) (f) (g) (h) (i)
NAME OTHER RESTRICTED
AND ANNUAL STOCK LTIP ALL OTHER
PRINCIPAL COMPEN- AWARDS OPTIONAL PAYOUTS COMPEN-
POSITION YEAR SALARY($) BONUS($) SATION($) ($) SAR'S(#) ($) SATION($)
(1)
- ------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
CARL HOROWITZ 1996 $150,000 $25,000 $10,836 $0 $0 $0 $7,460
CEO, PRESIDENT 1995 135,915 25,000 27,616 0 0 0 8,084
1994 130,471 25,000 28,093 0 0 0 4,490
IRENE HOROWITZ 1996 153,923 10,000 0 0 0 0 7,650
SENIOR VICE 1995 152,525 10,000 0 0 0 0 7,940
PRESIDENT 1994 144,452 10,000 0 0 0 0 4,474
JOHN M. RYAN 1996 241,167 20,000 0 0 0 3,524
EXECUTIVE VICE 1995 218,227 7,738 0 0 0 0 3,374
PRESIDENT 1994 191,154 7,511 0 0 0 0 12,002
MOHAN SANDUJA 1996 114,080 1,500 0 0 0 0 10,592
VICE PRESIDENT 1995 102,930 2,000 0 0 0 0 9,493
RESEARCH AND 1994 99,519 2,000 0 0 0 0 7,141
DEVELOPMENT
</TABLE>
(1) Represents premiums on officer's life insurance policy in which Mr. Horowitz
has the right to designate the beneficiary.
17
<PAGE>
STOCK OPTIONS
No executive officer owns any stock options.
EMPLOYMENT AGREEMENTS
On March 1, 1993, the Company and Carl Horowitz agreed to extend Mr. Horowitz's
employment agreement through May 16, 1998. Mr. Horowitz's maximum base salary
under the new agreement is $160,000 for 1996 with annual increases of $10,000
thereafter.
On July 26, 1994 the Company entered into retirement agreements with the
Company's President and Senior Vice President. The agreements set a compensation
rate of 60% of the average 5 preceding year's annual compensation, payable for
the remainder of the individuals' life. In addition the Company is to maintain
the individuals' medical benefits.
Directors who are not employees of the Company receive a fee of $500 for each
regular meeting of the Board of Directors that they attend.
Effective January 1, 1990, the Company adopted a qualified noncontributory
profit sharing plan. Eligible employees must meet two requirements to become
participants; attainment of age 21 and completion of one year of service with
the Company. Employer contributions, if any, are determined at the Board of
Directors' discretion. A percentage of the benefits vest after three years of
qualifying service.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT
The following table sets forth certain information, as of February 18, 1997,
with respect to each person known to the Company to be the beneficial owner of
more than 5% of the Company's Common Stock, each executive officer named on the
Summary Compensation table, and by all officers and directors as a group:
AMOUNT
NAME AND ADDRESS OF BENEFICIALLY PERCENTAGE
TITLE OF CLASS BENEFICIAL OWNER OWNED OF CLASS
- -------------- ---------------- ----- --------
Common stock
$.01 par value Carl Horowitz 361,206 24.2%
2719 Whitman Drive
Brooklyn, NY 11234
Irene Horowitz 32,507 2.2%
2719 Whitman Drive
Brooklyn, NY 11234
18
<PAGE>
John M. Ryan 16,637 1.1%
3035 Lonni Lane
Merrick, N.Y. 11566
Alice J. Horowitz 46,585 3.1%
3046 West Tonopah Drive
Phoenix, Arizona 85027
Boris Jody -0- 0.0%
4301 N. Ocean Blvd.
Boca Raton, Fl.
Anna Dichter 770 0.0%
1757 E. 54th Street
Brooklyn, N.Y.
George Sawey 74 0.0%
59 Squaw Brook Road
N. Haldon, N.J.
Terry J. Wolfgang 13,970 0.9%
440 West End Avenue
New York, N.Y. 10750
Dr. Mohan Sanduja -0- 0.0%
144-90 91st Avenue
Flushing, N.Y.
Clare Chamow -0- 0.0%
5613 Fillmore Avenue
Brooklyn, N.Y. 11234
Betty Friedman -0- 0.0%
7219 Avenue N
Brooklyn, N.Y. 11234
First Wilshire Securities 124,396 8.85%
Management Corp.
600 South Lake St.
Pasadena, CA 91106
All executive officers and directors 471,749 31.7%
as a group (11 in number)
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Other than legal fees paid, as disclosed in Item 10, there were no related party
transactions.
19
<PAGE>
ITEM 14. EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES, AND REPORTS
ON FORM 8-K
1. Financial Statements. See Item 8 above for a list of financial
statements included as part of this Annual Report on Form
10-K.
3. Exhibits
(3) Registrant's Certificate of Incorporation, as
amended, and By-Laws, as amended (incorporated by
reference as previously filed with the United States
Securities and Exchange Commission on January 7, 1986
on Form 10). Amendment to the Certificate of
Incorporation dated July 23, 1988, (incorporated by
reference as previously filed with the United States
Security and Exchange Commission in March 1991 with
Form 10K)
(10) Material Contracts
(.1) Employment Contract of Carl Horowitz, the
Company's President, dated March 1, 1993
(incorporated by reference as previously filed with
United States Security and Exchange Commission in
March, 1994 Form 10K).
(.2) Mortgage agreement between the Company and Tama
Realty Co., dated June 4, 1990 (incorporated by
reference as previously filed with the United States
Security and Exchange Commission in March 1991 with
Form 10K).
(.2A) Mortgage modification agreement between the
Company and Tama Realty Co., dated August 26, 1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
POLYMER RESEARCH CORP. OF AMERICA
/s/
--------------------------------
CARL HOROWITZ, President and
Chief Executive Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.
/s/ March 19, 1997
- ---------------------------- Director ----------------------
Carl Horowitz Date
/s/ March 19, 1997
- ---------------------------- Director ----------------------
Irene Horowitz Date
/s/ March 19, 1997
- ---------------------------- Director ----------------------
John M. Ryan Date
- ---------------------------- Director ----------------------
Alice J. Horowitz Date
- ---------------------------- Director ----------------------
Boris Jody Date
/s/ March 19, 1997
- ---------------------------- Director ----------------------
Dr. Mohan Sanduja, PhD Date
- ---------------------------- Director ----------------------
Terry Wolfgang Date
<PAGE>
EXHIBIT 10.2A
MORTGAGE MODIFICATION AGREEMENT
THIS AGREEMENT, made as of August 20, 1996,
BETWEEN: TAMA REALTY CO., 11 Rutland Road, Great Neck, New York 11020,
hereinafter designated "Tama"
AND: POLYMER RESEARCH CORP. OF AMERICA, 2186 Mill Avenue, Brooklyn, New
York 11234, hereinafter designated "Polymer"
WITNESSETH:
WHEREAS, Tama is the owner and holder of a Mortgage Note of Polymer for
$2,500,000.00 made the 4th day of June, 1990, and secured by a Mortgage recorded
in the office of the Register of Kings County, State of New York, in Reel 2565
at Page 1837, on June 6, 1990; and
WHEREAS, there will be due and owing upon the aforementioned Note and Mortgage
after the September, 1996 payment the principal sum of $2,317,744.84: and
WHEREAS, Polymer has requested that it be allowed to prepay the sum of
$800,000.00 and to modify its monthly payment; and
WHEREAS, the parties hereto are desirous of modifying the terms of the above
mentioned Note and Mortgage upon the terms hereinafter mentioned;
NOW, THEREFORE, in consideration of the premises and of the mutual promises
herein contained and the sum of One Dollar ($1.00) to each of the parties hereto
to the other duly paid, the receipt of which is hereby acknowledged, it is
hereby mutually covenanted and agreed that the terms of the payment of the
aforesaid Note and Mortgage be and the same are hereby modified to the extent
that Polymer pay to Tama on September 1, 1996 the sum of $800,000.00 in
reduction of the principal balance on the aforesaid Note and Mortgage together
with the sum of $45,000.00 as prepaid interest on such amount, and that Polymer
shall thereafter pay to Tama $15,457.13 in equal monthly installments commencing
October 1, 1996. Said payments shall be continued until the first day of June,
2000, on which date the whole of the principal sum then remaining due on said
indebtedness, together with the interest which may be due, shall become due and
payable.
This agreement is made upon the express condition and Polymer covenants that it
is the owner of the premises described in the said Mortgage and that there are
no defects or defenses to the said Note and Mortgage; and that Tama Realty Co.
covenants that it is the sole holder of the mortgage, has not assigned the
mortgage or any interest therein and that this Agreement has been
<PAGE>
duly authorized and executed by or on behalf of Tama and constitutes the legal,
valid and binding obligation of Tama enforceable in accordance with its terms.
Nothing herein contained shall invalidate any of the security now held for the
said indebtedness, nor impair any of the terms, conditions, covenants and
provisions of the said Note and Mortgage, except as herein specifically
modified.
This agreement shall bind the parties hereto, their successors, heirs, legal
representatives and assigns.
IN WITNESS WHEREOF, the parties hereto have caused this agreement to be duly
executed the day and year first above written.
WITNESS: TAMA REALTY CO.
/s/Marvin A. Bass By: /s/ Elaine Bass
------------------------------
ELAINE BASS
WITNESS: POLYMER RESEARCH CORP. OF AMERICA
/s/ Ella Maystich By: /s/ Carl Horowitz Pres.
------------------------------
CARL HOROWITZ, President
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the December
31, 1996 audited financial statements and is qualified as its entirety by
reference to such financial statements.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 12-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-01-1996
<PERIOD-END> DEC-01-1996
<CASH> 1,263,000
<SECURITIES> 473,000
<RECEIVABLES> 91,000
<ALLOWANCES> 0
<INVENTORY> 85,000
<CURRENT-ASSETS> 2,109,000
<PP&E> 3,742,000
<DEPRECIATION> 802,000
<TOTAL-ASSETS> 5,060,000
<CURRENT-LIABILITIES> 896,000
<BONDS> 1,483,000
0
0
<COMMON> 14,900
<OTHER-SE> 2,735,000
<TOTAL-LIABILITY-AND-EQUITY> 5,060,000
<SALES> 752,145
<TOTAL-REVENUES> 5,078,000
<CGS> 623,000
<TOTAL-COSTS> 2,680,000
<OTHER-EXPENSES> 490,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 272,000
<INCOME-PRETAX> 327,000
<INCOME-TAX> 157,000
<INCOME-CONTINUING> 170,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 170,000
<EPS-PRIMARY> .12
<EPS-DILUTED> .12
</TABLE>
